Skip to main content
. 2017 Jul 13;12(7):e0179764. doi: 10.1371/journal.pone.0179764

Fig 1. Sustained virological response (SVR) 12 weeks after end of treatment, according to different sofosbuvir based treatment regimens and stage of liver disease in patients with chronic HCV genotype 3 infection (n = 311).

Fig 1

*Data on 24 patients with cirrhotic patients is not included due to missing CP score.